These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 31225926)

  • 1. Mevalonate pathway activity as a determinant of radiation sensitivity in head and neck cancer.
    Ricco N; Flor A; Wolfgeher D; Efimova EV; Ramamurthy A; Appelbe OK; Brinkman J; Truman AW; Spiotto MT; Kron SJ
    Mol Oncol; 2019 Sep; 13(9):1927-1943. PubMed ID: 31225926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of different response to ionizing irradiation in isogenic head and neck cancer cell lines.
    Todorovic V; Prevc A; Zakelj MN; Savarin M; Brozic A; Groselj B; Strojan P; Cemazar M; Sersa G
    Radiat Oncol; 2019 Nov; 14(1):214. PubMed ID: 31775835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Senescence Induction by Combined Ionizing Radiation and DNA Damage Response Inhibitors in Head and Neck Squamous Cell Carcinoma Cells.
    Dobler C; Jost T; Hecht M; Fietkau R; Distel L
    Cells; 2020 Sep; 9(9):. PubMed ID: 32883016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MitoTam induces ferroptosis and increases radiosensitivity in head and neck cancer cells.
    Reinema FV; Hudson N; Adema GJ; Peeters WJM; Neuzil J; Stursa J; Werner L; Sweep FCGJ; Bussink J; Span PN
    Radiother Oncol; 2024 Nov; 200():110503. PubMed ID: 39186982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The NEDD8 conjugation pathway regulates p53 transcriptional activity and head and neck cancer cell sensitivity to ionizing radiation.
    Guihard S; Ramolu L; Macabre C; Wasylyk B; Noël G; Abecassis J; Jung AC
    Int J Oncol; 2012 Oct; 41(4):1531-40. PubMed ID: 22895816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbonyl reductase 1 is a new target to improve the effect of radiotherapy on head and neck squamous cell carcinoma.
    Yun M; Choi AJ; Lee YC; Kong M; Sung JY; Kim SS; Eun YG
    J Exp Clin Cancer Res; 2018 Oct; 37(1):264. PubMed ID: 30376862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PARP Inhibition Enhances Radiotherapy of SMAD4-Deficient Human Head and Neck Squamous Cell Carcinomas in Experimental Models.
    Hernandez AL; Young CD; Bian L; Weigel K; Nolan K; Frederick B; Han G; He G; Devon Trahan G; Rudolph MC; Jones KL; Oweida AJ; Karam SD; Raben D; Wang XJ
    Clin Cancer Res; 2020 Jun; 26(12):3058-3070. PubMed ID: 32139402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Periostin Plays a Key Role in Radioresistance of Head and Neck Cancer Cells
    Park JJ; Hah YS; Ryu S; Cheon SY; Cho HY; Kim JP; Won SJ; Lee JS; Hwa JS; Seo JH; Chang HW; Kim SY
    Anticancer Res; 2020 May; 40(5):2627-2635. PubMed ID: 32366407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of PI3K inhibition on the radiotherapy response of head and neck cancer cells.
    Glorieux M; Dok R; Nuyts S
    Sci Rep; 2020 Oct; 10(1):16208. PubMed ID: 33004905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TIPRL1 and its ATM-dependent phosphorylation promote radiotherapy resistance in head and neck cancer.
    Cokelaere C; Dok R; Cortesi EE; Zhao P; Sablina A; Nuyts S; Derua R; Janssens V
    Cell Oncol (Dordr); 2024 Jun; 47(3):793-818. PubMed ID: 37971644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. c-Abl Tyrosine Kinase Is Regulated Downstream of the Cytoskeletal Protein Synemin in Head and Neck Squamous Cell Carcinoma Radioresistance and DNA Repair.
    Deville SS; Delgadillo Silva LF; Vehlow A; Cordes N
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33019757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive analysis of radiosensitivity in head and neck squamous cell carcinoma.
    Li G; Jiang Y; Li G; Qiao Q
    Radiother Oncol; 2021 Jun; 159():126-135. PubMed ID: 33775714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of lncRNA LINC00473 promotes radioresistance of HNSCC cells through activating Wnt/β-catenin signaling pathway.
    Han PB; Ji XJ; Zhang M; Gao LY
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7305-7313. PubMed ID: 30468475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survivin/BIRC5 as a novel molecular effector at the crossroads of glucose metabolism and radioresistance in head and neck squamous cell carcinoma.
    Benaiges E; Ceperuelo-Mallafré V; Guaita S; Maymó-Masip E; Madeira A; Gómez D; Hernández V; Vilaseca I; Merma C; León X; Terra X; Vendrell J; Avilés-Jurado FX; Fernández-Veledo S
    Head Neck; 2024 Jul; 46(7):1752-1765. PubMed ID: 38305029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radioresistant head and neck squamous cell carcinoma cells: intracellular signaling, putative biomarkers for tumor recurrences and possible therapeutic targets.
    Skvortsov S; Jimenez CR; Knol JC; Eichberger P; Schiestl B; Debbage P; Skvortsova I; Lukas P
    Radiother Oncol; 2011 Oct; 101(1):177-82. PubMed ID: 21700351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autophagy is the main driver of radioresistance of HNSCC cells in mild hypoxia.
    Hill RM; Li C; Hughes JR; Rocha S; Grundy GJ; Parsons JL
    J Cell Mol Med; 2024 Jun; 28(12):e18482. PubMed ID: 38899556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radioresistance or/and radiosensitivity of head and neck squamous cell carcinoma: biological angle.
    Li CX; Gong ZC; Zhang WN; Zhang Y; Zhao HR
    Oral Maxillofac Surg; 2024 Jun; 28(2):547-555. PubMed ID: 37935817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic regulation of p62/SQSTM1 overcomes the radioresistance of head and neck cancer cells via autophagy-dependent senescence induction.
    Lee M; Nam HY; Kang HB; Lee WH; Lee GH; Sung GJ; Han MW; Cho KJ; Chang EJ; Choi KC; Kim SW; Kim SY
    Cell Death Dis; 2021 Mar; 12(3):250. PubMed ID: 33674559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of the CCR6-CCL20 axis prevents regulatory T cell recruitment and sensitizes head and neck squamous cell carcinoma to radiation therapy.
    Rutihinda C; Haroun R; Saidi NE; Ordoñez JP; Naasri S; Lévesque D; Boisvert FM; Fortier PH; Belzile M; Fradet L; Hubert-Tremblay V; Turgeon GA; Wang CS; Delage P; Rousseau É; Paquette B; Oweida AJ
    Cancer Immunol Immunother; 2023 May; 72(5):1089-1102. PubMed ID: 36326893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic amplification of Fanconi anemia complementation group A (FancA) in head and neck squamous cell carcinoma (HNSCC): Cellular mechanisms of radioresistance and clinical relevance.
    Hess J; Unger K; Orth M; Schötz U; Schüttrumpf L; Zangen V; Gimenez-Aznar I; Michna A; Schneider L; Stamp R; Selmansberger M; Braselmann H; Hieber L; Drexler GA; Kuger S; Klein D; Jendrossek V; Friedl AA; Belka C; Zitzelsberger H; Lauber K
    Cancer Lett; 2017 Feb; 386():87-99. PubMed ID: 27867017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.